Previous 10 | Next 10 |
Less than 1% device-related complication rates reported in post market surveillance data over 12+ years. Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and r...
Establishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has entered into agreements with four partners in Europe and a second partner cha...
Summary Establishment Labs' top-line growth was commendable with upsides in key markets, especially Brazil. FY23 is undoubtedly a major inflection point for the company, with numerous product launches set. Management seems constructive on forward-estimates, looking for $500mm in rev...
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, an...
Establishment Labs Holdings Inc. (ESTA) Q4 2022 Earnings Conference Call February 27, 2023, 04:30 PM ET Company Participants Raj Denhoy - Chief Financial Officer Juan Jose Chacon-Quiros - Chief Executive Officer Conference Call Participants Zach Weiner - Jeffer...
Establishment Labs press release ( NASDAQ: ESTA ): Q4 GAAP EPS of -$0.55 beats by $0.13 . Revenue of $43.81M (+24.1% Y/Y) beats by $0.73M . Fourth and final module submitted to U.S. FDA for premarket approval of Motiva Implants ® . 2023 guidance ...
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that it has submitted the fourth and final module of its modular submission to the F...
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended December 31, 2022, after the market cl...
Establishment Labs ( NASDAQ: ESTA ) expects Q4 revenue to be in the range of $43.3M to $44.3M, representing growth of 23% to 25% Y/Y vs consensus of $42.81M , growth in the fourth quarter is expected to be 27% to 29%. Fiscal year 2022 revenue is expected to be in the rang...
Fourth-quarter revenue is expected to be in the range of $43.3 million to $44.3 million, representing growth of 23% to 25% over the same period in 2021; excluding the effects of changes in foreign currency exchange rates, growth in the fourth quarter is expected to be 27% to 29%. Fiscal year ...
News, Short Squeeze, Breakout and More Instantly...
Establishment Labs Holdings Inc. Company Name:
ESTA Stock Symbol:
NASDAQ Market:
Establishment Labs Holdings Inc. Website:
Findell Capital Management LLC Releases Comprehensive Research Coverage Report on ESTA : Nasdaq NEW YORK, NY, June 17, 2024 - (ACN Newswire) - Findell Capital Management LLC, an investment management firm, today announced the release of a detailed Report on Establishment Labs Holdin...
--News Direct-- New York, NY, June 17, 2024 – Findell Capital Management LLC , an investment management firm, today announced the release of a detailed Report on Establishment Labs Holdings Inc. (Nasdaq: ESTA), which can be found here . ESTA is a NASDAQ listed c...
2024-05-20 18:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...